Blueprint: Blackstone’s $3.4bn life science deal with Brookfield, MARK hits its hard-cap, Prologis’s logistics outlook

What Blackstone’s $3.45 billion portfolio acquisition says about life science; how the firm formerly known as Meyer Bergman fared with its first fund; Prologis’s outlook on logistics demand; and more in today's briefing, exclusively for our valued subscribers.

PRIVATE REAL ESTATE

Register to unlock this content

• Daily global private real estate news and market intelligence
• Expertly curated insights to keep you ahead of the market
• Faster, data-driven decision-making powered by our AI interface, Ask PEI
• Access to proprietary research and reports
• Selected investor strategy and competitor performance data

Register nowFind out more

Blueprint